Kamijo-Ikemori A - Search Results

1

Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.

Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K. Kamijo-Ikemori A, et al. Nephrology (Carlton). 2011 Aug;16(6):539-44. doi: 10.1111/j.1440-1797.2011.01469.x. Nephrology (Carlton). 2011. PMID: 21504508 Review.

2

Urinary fatty acid binding protein in renal disease.

Kamijo-Ikemori A, Sugaya T, Kimura K. Kamijo-Ikemori A, et al. Clin Chim Acta. 2006 Dec;374(1-2):1-7. doi: 10.1016/j.cca.2006.05.038. Epub 2006 Jun 3. Clin Chim Acta. 2006. PMID: 16860300 Review.

3

Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.

Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K. Kamijo-Ikemori A, et al. Am J Pathol. 2006 Oct;169(4):1107-17. doi: 10.2353/ajpath.2006.060131. Am J Pathol. 2006. PMID: 17003471 Free PMC article.

4

Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.

Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K. Kamijo-Ikemori A, et al. Nephrol Dial Transplant. 2009 Mar;24(3):788-800. doi: 10.1093/ndt/gfn573. Epub 2008 Oct 14. Nephrol Dial Transplant. 2009. PMID: 18854419

5

Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.

Sasaki H, Kamijo-Ikemori A, Sugaya T, Yamashita K, Yokoyama T, Koike J, Sato T, Yasuda T, Kimura K. Sasaki H, et al. Nephron Clin Pract. 2009;112(3):c148-56. doi: 10.1159/000214210. Epub 2009 Apr 24. Nephron Clin Pract. 2009. PMID: 19390215

6

Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.

Yokoyama T, Kamijo-Ikemori A, Sugaya T, Hoshino S, Yasuda T, Kimura K. Yokoyama T, et al. Am J Pathol. 2009 Jun;174(6):2096-106. doi: 10.2353/ajpath.2009.080780. Epub 2009 May 12. Am J Pathol. 2009. PMID: 19435794 Free PMC article.

7

Clinical significance of tubular and podocyte biomarkers in acute kidney injury.

Matsui K, Kamijo-Ikemori A, Hara M, Sugaya T, Kodama T, Fujitani S, Taira Y, Yasuda T, Kimura K. Matsui K, et al. Clin Exp Nephrol. 2011 Apr;15(2):220-5. doi: 10.1007/s10157-010-0384-y. Epub 2010 Dec 14. Clin Exp Nephrol. 2011. PMID: 21153750

8

Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.

Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K. Kamijo-Ikemori A, et al. Diabetes Care. 2011 Mar;34(3):691-6. doi: 10.2337/dc10-1392. Epub 2011 Jan 27. Diabetes Care. 2011. PMID: 21273494 Free PMC article.

9

[Urinary liver type fatty acid binding protein (L-FABP)].

Kamijo-Ikemori A, Sugaya T. Kamijo-Ikemori A, et al. Nihon Rinsho. 2010 Nov;68 Suppl 9:406-9. Nihon Rinsho. 2010. PMID: 21667494 Japanese. No abstract available.

10

Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults.

Matsui K, Kamijo-Ikemori A, Sugaya T, Yasuda T, Kimura K. Matsui K, et al. Circ J. 2012;76(1):213-20. doi: 10.1253/circj.cj-11-0342. Epub 2011 Nov 18. Circ J. 2012. PMID: 22094907 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters